Global Cord Blood (CO) Competitors $1.05 0.00 (0.00%) As of 09/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock CO vs. CORBF, MRAI, ZVRA, MBX, EOLS, SRDX, ALMS, CMPX, LAB, and VREXShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Global Cord Blood (CORBF), Marpai (MRAI), Zevra Therapeutics (ZVRA), MBX Biosciences (MBX), Evolus (EOLS), Surmodics (SRDX), Alumis (ALMS), Compass Therapeutics (CMPX), Standard BioTools (LAB), and Varex Imaging (VREX). Global Cord Blood vs. Its Competitors Global Cord Blood Marpai Zevra Therapeutics MBX Biosciences Evolus Surmodics Alumis Compass Therapeutics Standard BioTools Varex Imaging Global Cord Blood (NYSE:CORBF) and Global Cord Blood (NYSE:CO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment. Is CORBF or CO more profitable? Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Global Cord Blood N/A N/A N/A Which has higher valuation & earnings, CORBF or CO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$196.12M0.65$79.04MN/AN/AGlobal Cord Blood$1.24B0.10$79.04M$0.641.64 Does the media favor CORBF or CO? In the previous week, Global Cord Blood's average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score. Company Overall Sentiment Global Cord Blood Neutral Global Cord Blood Neutral Which has more risk and volatility, CORBF or CO? Global Cord Blood has a beta of -0.6, suggesting that its share price is 160% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. SummaryGlobal Cord Blood beats Global Cord Blood on 2 of the 3 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CO vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$127.63M$92.28M$5.79B$21.44BDividend YieldN/AN/A5.28%3.50%P/E Ratio1.640.8275.7829.64Price / Sales0.100.46513.1968.86Price / Cash4.192.8037.2024.61Price / Book0.170.1711.354.56Net Income$79.04M$43.11M$3.28B$999.91M7 Day PerformanceN/A-3.57%1.25%1.32%1 Month PerformanceN/A-17.05%11.47%5.63%1 Year Performance-30.00%16.34%59.18%17.12% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGlobal Cord BloodN/A$1.05flatN/A-30.0%$127.63M$1.24B1.641,202CORBFGlobal Cord BloodN/A$1.05flatN/A-30.0%$127.63M$196.12M0.001,200MRAIMarpaiN/A$1.39+0.7%N/A+129.9%$24.01M$34.87M-0.53150ZVRAZevra Therapeutics2.8434 of 5 stars$9.07-2.5%$23.71+161.5%+13.6%$509.14M$23.61M-43.1920Positive NewsShort Interest ↑MBXMBX Biosciences2.825 of 5 stars$15.09+5.7%$37.63+149.3%N/A$506.93MN/A-3.3236Positive NewsEOLSEvolus4.5543 of 5 stars$7.63+1.5%$21.25+178.5%-51.0%$493.55M$266.27M-7.79170News CoveragePositive NewsAnalyst ForecastShort Interest ↓SRDXSurmodics4.3678 of 5 stars$34.04-0.8%$43.00+26.3%-16.5%$486.69M$126.08M-27.67450Positive NewsALMSAlumis2.8877 of 5 stars$4.64-1.3%$20.17+334.6%-63.8%$482.86MN/A0.00N/ACMPXCompass Therapeutics2.7708 of 5 stars$3.49flat$12.89+269.3%+118.9%$482.61M$850K-7.7620Positive NewsLABStandard BioTools2.7295 of 5 stars$1.26-2.3%$1.55+23.0%-35.7%$481.31M$174.43M-3.94620Positive NewsVREXVarex Imaging4.6875 of 5 stars$11.55+0.7%$19.50+68.8%+13.3%$479.33M$811M-3.602,300Positive News Related Companies and Tools Related Companies CORBF Competitors MRAI Competitors ZVRA Competitors MBX Competitors EOLS Competitors SRDX Competitors ALMS Competitors CMPX Competitors LAB Competitors VREX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CO) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CO Stock Alerts